FARXIGA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Oct 2025)
What this means for you
Registered since 28 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88639033
- Registration number
- 6042465
- Mark type
- Stylized text
- Filed
- 02 Oct 2019
- Published for opposition
- 11 Feb 2020
- Registered
- 28 Apr 2020
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prior registrations
Prosecution history
- 23 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 28 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 22 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 11 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2020 — PUBLISHED FOR OPPOSITION
- 22 Jan 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED